Dr. José Baselga, the hospital’s chief medical officer, stepped down days after a report by ProPublica and the New York Times that he failed to disclose millions of dollars in payments from the health care and drug industry in research articles.
The revelations about Baselga’s disclosure lapses, reported by The New York Times and ProPublica last weekend, have rocked Memorial Sloan Kettering, one of the nation’s leading cancer centers, in recent days.
Its top executives scrambled to contain the fallout, including urgent meetings of physician leaders and the executive committee of its board of directors of drugmaker Bristol-Myers Squibb.
To read the story by ProPublica
